Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.

Selina HeinJennifer FurkelMaximilian KnollFabian Aus dem SiepenStefan SchönlandUte HegenbartHugo A KatusArnt V KristenMathias H Konstandin

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2021)

Attenuated cardiomyocyte growth response after stimulation with patient plasma in vitro is an independent risk factor for adverse cardiac events in ATTR patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
left ventricular
prognostic factors
emergency department
heart failure
case report
electronic health record
wild type